Status:
COMPLETED
Evaluation and Natural History of Children With Cancer and AIDS
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Acquired Immunodeficiency Syndrome
Cancer
Eligibility:
All Genders
Brief Summary
Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experi...
Detailed Description
This protocol will enable the Pediatric Branch to follow selected children with cancer or HIV infection who are not immediately eligible for protocol enrollment but who are likely, within the next yea...
Eligibility Criteria
Children with cancer (or a precancer syndrome) or HIV infection, between the age(s) of 3 months to 30 years, who are evaluated by the Pediatric Branch and are found to be not immediately eligible for an ongoing protocol but are likely to become a candidate for a future protocol.
Children with cancer (or a precancer syndrome) or HIV infection, who present with disease manifestations of special interest to Pediatric Branch investigators, because they are likely to shed light on disease.
Patients who, when evaluated by the Branch, are determined to likely never become eligible for a Pediatric Branch protocol are not eligible for this protocol.
No patients younger than 3 months of age or older than 30 years of age are eligible for this protocol.
Key Trial Info
Start Date :
November 1 1994
Trial Type :
OBSERVATIONAL
End Date :
August 1 2000
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00001424
Start Date
November 1 1994
End Date
August 1 2000
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892